Skip to Main Content

Paper Details

Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
Cell
229
2018
AR, AR locus, CDK12, Castration-Resistant Prostate Cancer, MYC enhancer, cell, mCRPC, metastatic castration-resistant prostate cancer, non-coding, patients, prostate cancer, prostate cancer genes, prostate cancers, upstream enhancer
Author NameAffiliation
Jeremiah WalaDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, USA Harvard Medical School
Jeremiah WalaDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, USA Harvard Medical School
Nicholas J HaradhvalaBroad Institute of MIT and Harvard, USA Cancer Center and Department of Pathology, Massachusetts General Hospital
Samuel S FreemanBroad Institute of MIT and Harvard, USA Harvard Medical School
Samuel S FreemanBroad Institute of MIT and Harvard, USA Harvard Medical School
Paz PolakIcahn School of Medicine at Mount Sinai
Paz PolakIcahn School of Medicine at Mount Sinai
Michelle CipicchioBroad Institute of MIT and Harvard
Stephanie A WankowiczDana-Farber Cancer Institute, Broad Institute of MIT and Harvard
Gad GetzBroad Institute of MIT and Harvard, USA Cancer Center and Department of Pathology, Massachusetts General Hospital, USA Harvard Medical School
Gad GetzBroad Institute of MIT and Harvard, USA Cancer Center and Department of Pathology, Massachusetts General Hospital, USA Harvard Medical School
Stacey GabrielBroad Institute of MIT and Harvard
Stacey GabrielBroad Institute of MIT and Harvard
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Eliezer M Van AllenDana-Farber Cancer Institute, Broad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute, Broad Institute of MIT and Harvard
Rameen BeroukhimDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, USA Brigham and Women's Hospital
Mary-Ellen TaplinDana-Farber Cancer Institute, USA Harvard Medical School
Matthew MeyersonDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, USA Harvard Medical School, USA Brigham and Women's Hospital
Matthew MeyersonDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, USA Harvard Medical School, USA Brigham and Women's Hospital
  • 1 - 21

Datasets